News

Essential Insights on SS&C Technologies Holdings Earnings

Essential Insights on SS&C Technologies Holdings Earnings

Overview of SS&C Technologies Holdings

SS&C Technologies Holdings Inc (NASDAQ: SSNC) is gearing up to release its quarterly earnings report soon. Investors are eagerly awaiting details that might go beyond the expected outcomes, particularly after the company's previous performances have shown promise.

What to Expect from the Earnings Report

Analysts project that SS&C will report an earnings per share (EPS) of $1.42, a figure that reflects ongoing stability and potential growth. The anticipation regarding this earnings call is high, particularly given the company's history of exceeding expectations.

Review of Previous Earnings

In its last quarter, SS&C managed to beat EPS estimates by $0.11, which significantly impacted its share price, resulting in a notable increase of 2.61% on the day following the announcement. These upward trends in performance indicate a healthy market sentiment regarding the stock.

Historical Performance Metrics

The last few quarters have shown consistency in SS&C's performance. Over the last year, its EPS estimates have fluctuated but overall displayed a positive trajectory:

  • Q2 2025: Estimated EPS: 1.34 | Actual EPS: 1.45 | Price Change: 3.00%
  • Q1 2025: Estimated EPS: 1.41 | Actual EPS: 1.44 | Price Change: -6.00%
  • Q4 2024: Estimated EPS: 1.33 | Actual EPS: 1.58 | Price Change: 6.00%
  • Q3 2024: Estimated EPS: 1.26 | Actual EPS: 1.29 | Price Change: -7.00%

Current Stock Performance

As of October 21, SS&C's shares traded at approximately $82.50. The stock has shown a 10.24% increase over the past year, signaling a positive outlook among long-term investors as the company approaches this earnings release.

Analyst Recommendations

Keeping track of industry sentiment is vital for investors. Currently, SS&C holds a consensus rating of 'Buy' from analysts, who assign an average one-year price target of $99.75. This suggests a promising upside of 20.91%, reinforcing positive expectations for the company.

Peer Comparisons

Looking at major competitors in the market, several peer ratings have surfaced, providing context for SS&C's standing:

  • Broadridge Financial is rated as Neutral with a price target of $282.00, indicating a potentially large upside.
  • Genpact holds a Buy rating, though its average price target suggests a slight downside.
  • ExlService Holdings has an Outperform rating but reflects some downside.

Comprehensive Market Standing

In terms of financial metrics, SS&C Technologies shows impressive revenue growth, leading among its peers:

  • Revenue Growth: 5.88%
  • Gross Profit: $736.90 million
  • Return on Equity (ROE): 2.64%

Background of SS&C Technologies

SS&C has built a strong reputation by providing innovative software products and services primarily in the financial sector. Over the years, strategic acquisitions have bolstered its market position, including notable acquisitions like Intralinks and Blue Prism, enhancing its capabilities in portfolio management and healthcare solutions.

Financial Overview

The company's market capitalization reflects its substantial market presence. Despite some challenges in optimizing returns on equity and assets, SS&C's debt-to-equity ratio of 1.01 signals a responsible approach to leveraging financial resources.

Frequently Asked Questions

What are the expected earnings for SS&C Technologies?

Analysts expect an earnings per share of $1.42 for the upcoming report.

How has SS&C performed in previous quarters?

In the last quarter, SS&C reported an EPS beat of $0.11, leading to a price increase of 2.61%.

What is the current stock price of SS&C Technologies?

As of October 21, SS&C's shares were trading at approximately $82.50.

What do analysts say about SS&C's stock?

Analysts rate SS&C as a 'Buy' with a price target of $99.75, indicating significant potential upside.

How does SS&C compare with its peers?

SS&C ranks favorably in revenue growth but faces challenges relative to ROE compared to its industry peers.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 401

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 169

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 392

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 390

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 296

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 322

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 219

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 337

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 165

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

Rick Howard Joins Knowtion Health as New CTO to Drive Innovation

Updated Category News Views 422

Rick Howard Appointed as Chief Technology Officer of Knowtion Health Knowtion Health, a prominent name in healthcare revenue cycle management, has announced its latest executive appointment. Rick Howard has joined the team as the Chief Technology Officer, bringing with him over 20 years of invaluable experience in healthcare information technology, artificial...

Continue Reading
Exploring the Untold Broadway Dream of Andy Warhol

Updated Category News Views 187

An Artistic Collaboration That Never Was A never-before-seen slice of advertising and pop culture history is coming to light. In a recent video profile, David Bartels, a veteran ad man, recounts the story of a potential Broadway collaboration with the legendary artist Andy Warhol. This ambitious project was a dazzling, provocative stage production that almost materialized...

Continue Reading
CSL Vifor and Travere Therapeutics Embrace New IgAN Guidelines

Updated Category News Views 256

Introduction to IgA Nephropathy Management The landscape of IgA Nephropathy (IgAN) treatment is evolving, and the recent updates from CSL Vifor and Travere Therapeutics mark a significant milestone. These updated clinical practice guidelines set forth by KDIGO provide a comprehensive approach to diagnosing and treating IgAN, aiming to improve outcomes for those affected...

Continue Reading
Major Insider Purchase by Christopher L Mapes at Nordson

Updated Category News Views 209

Significant Insider Purchase at Nordson In a notable move within the corporate landscape, Christopher L Mapes, who serves as the Director at Nordson (NASDAQ: NDSN), recently made a considerable investment in the company. According to recent filings, Mapes purchased 930 shares of Nordson, amounting to an impressive total of $215,713. This proactive step signals a strong...

Continue Reading
Baijiayun Group Honored as Leader in Future Medical Technology

Updated Category News Views 143

Baijiayun Group Honored for Medical Technology Innovation Baijiayun Group Ltd, known for its exceptional contributions in AI video solutions, has proudly received the title of "2024 Future Medical Technology Leader." This award highlights the company's commitment to enhancing medical technologies and practices through innovative video solutions. Leading the Charge in AI...

Continue Reading